Sharon Klahre | Vice President of Investor Relations and Strategic Finance |
Ankit Mahadevia | Chief Executive Officer |
David Melnick | Chief Medical Officer |
Cristina Larkin | Chief Operating Officer |
Sath Shukla | Chief Financial Officer |
Lyla Youssef | Cowen & Company |
Louise Chen | Cantor Fitzgerald |
Kevin DeGeeter | Oppenheimer |
Esther Hong | Berenberg |
Ram Selvaraju | H.C. Wainwright |
Greetings, and welcome to Spero Therapeutics Fourth Quarter and Full Year 2020 Financial Results Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded. It is now my pleasure to introduce your host for today's call Sharon Klahre.